MSFT   206.99 (+1.12%)
FB   234.88 (-1.12%)
GOOGL   1,457.42 (+1.07%)
AMZN   2,885.89 (+0.25%)
CGC   16.37 (-0.61%)
TSLA   1,193.82 (+6.63%)
T   30.09 (+0.60%)
F   6.03 (+0.67%)
GILD   76.25 (+0.25%)
BAC   23.26 (-0.04%)
NFLX   479.10 (-1.35%)
BA   181.24 (+0.51%)
MSFT   206.99 (+1.12%)
FB   234.88 (-1.12%)
GOOGL   1,457.42 (+1.07%)
AMZN   2,885.89 (+0.25%)
CGC   16.37 (-0.61%)
TSLA   1,193.82 (+6.63%)
T   30.09 (+0.60%)
F   6.03 (+0.67%)
GILD   76.25 (+0.25%)
BAC   23.26 (-0.04%)
NFLX   479.10 (-1.35%)
BA   181.24 (+0.51%)
MSFT   206.99 (+1.12%)
FB   234.88 (-1.12%)
GOOGL   1,457.42 (+1.07%)
AMZN   2,885.89 (+0.25%)
CGC   16.37 (-0.61%)
TSLA   1,193.82 (+6.63%)
T   30.09 (+0.60%)
F   6.03 (+0.67%)
GILD   76.25 (+0.25%)
BAC   23.26 (-0.04%)
NFLX   479.10 (-1.35%)
BA   181.24 (+0.51%)
MSFT   206.99 (+1.12%)
FB   234.88 (-1.12%)
GOOGL   1,457.42 (+1.07%)
AMZN   2,885.89 (+0.25%)
CGC   16.37 (-0.61%)
TSLA   1,193.82 (+6.63%)
T   30.09 (+0.60%)
F   6.03 (+0.67%)
GILD   76.25 (+0.25%)
BAC   23.26 (-0.04%)
NFLX   479.10 (-1.35%)
BA   181.24 (+0.51%)
Log in

NYSE:ABCAmerisourceBergen Stock Price, Forecast & News

$100.57
+1.12 (+1.13 %)
(As of 07/2/2020 11:24 AM ET)
Add
Compare
Today's Range
$100.02
Now: $100.57
$101.62
50-Day Range
$84.03
MA: $95.65
$102.30
52-Week Range
$72.06
Now: $100.57
$103.37
Volume137,379 shs
Average Volume1.35 million shs
Market Capitalization$20.46 billion
P/E Ratio13.21
Dividend Yield1.67%
Beta0.61
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; offers specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in both the companion animal and production animal markets, as well as provides demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.
Read More
AmerisourceBergen logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.4Community Rank: 2.5Dividend Strength: 4.2Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.18 out of 5 stars


Industry, Sector and Symbol

Industry Drugs, proprietaries, & sundries
Sub-IndustryHealth Care Distributors
SectorMedical
CUSIP03073E10
Phone610-727-7000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$179.59 billion
Cash Flow$9.65 per share
Book Value$14.48 per share

Profitability

Net Income$855.36 million

Miscellaneous

Employees22,000
Market Cap$20.46 billion
Next Earnings Date8/6/2020 (Estimated)
OptionableOptionable

Receive ABC News and Ratings via Email

Sign-up to receive the latest news and ratings for ABC and its competitors with MarketBeat's FREE daily newsletter.

AmerisourceBergen (NYSE:ABC) Frequently Asked Questions

How has AmerisourceBergen's stock been impacted by COVID-19 (Coronavirus)?

AmerisourceBergen's stock was trading at $84.96 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ABC stock has increased by 18.6% and is now trading at $100.77. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of AmerisourceBergen?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AmerisourceBergen in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for AmerisourceBergen.

When is AmerisourceBergen's next earnings date?

AmerisourceBergen is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for AmerisourceBergen.

How were AmerisourceBergen's earnings last quarter?

AmerisourceBergen Corp. (NYSE:ABC) issued its quarterly earnings data on Thursday, May, 7th. The company reported $2.40 EPS for the quarter, topping the consensus estimate of $2.27 by $0.13. The firm had revenue of $47.42 billion for the quarter, compared to the consensus estimate of $45.90 billion. AmerisourceBergen had a net margin of 0.85% and a return on equity of 48.85%. AmerisourceBergen's revenue was up 9.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.11 earnings per share. View AmerisourceBergen's earnings history.

How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?

AmerisourceBergen announced a quarterly dividend on Thursday, January 30th. Shareholders of record on Friday, February 14th will be given a dividend of $0.42 per share on Monday, March 2nd. This represents a $1.68 dividend on an annualized basis and a dividend yield of 1.67%. The ex-dividend date is Thursday, February 13th. This is an increase from AmerisourceBergen's previous quarterly dividend of $0.40. View AmerisourceBergen's dividend history.

What guidance has AmerisourceBergen issued on next quarter's earnings?

AmerisourceBergen updated its FY20 earnings guidance on Thursday, May, 7th. The company provided earnings per share (EPS) guidance of $7.35-7.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.57.

What price target have analysts set for ABC?

8 brokers have issued 12 month target prices for AmerisourceBergen's stock. Their forecasts range from $98.00 to $112.00. On average, they anticipate AmerisourceBergen's stock price to reach $105.25 in the next twelve months. This suggests a possible upside of 4.4% from the stock's current price. View analysts' price targets for AmerisourceBergen.

Has AmerisourceBergen been receiving favorable news coverage?

Media coverage about ABC stock has been trending very negative this week, InfoTrie reports. InfoTrie ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. AmerisourceBergen earned a coverage optimism score of -3.3 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news about AmerisourceBergen.

Are investors shorting AmerisourceBergen?

AmerisourceBergen saw a drop in short interest during the month of June. As of June 15th, there was short interest totaling 3,820,000 shares, a drop of 8.0% from the May 31st total of 4,150,000 shares. Based on an average daily volume of 1,790,000 shares, the short-interest ratio is currently 2.1 days. Approximately 2.6% of the company's stock are sold short. View AmerisourceBergen's Current Options Chain.

Who are some of AmerisourceBergen's key competitors?

What other stocks do shareholders of AmerisourceBergen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AmerisourceBergen investors own include Intel (INTC), Walt Disney (DIS), AbbVie (ABBV), CVS Health (CVS), Cisco Systems (CSCO), NVIDIA (NVDA), Netflix (NFLX), Pfizer (PFE), JPMorgan Chase & Co. (JPM) and Gilead Sciences (GILD).

Who are AmerisourceBergen's key executives?

AmerisourceBergen's management team includes the following people:
  • Mr. Steven H. Collis, Chairman, Pres & CEO (Age 58)
  • Mr. James F. Cleary Jr., CFO & Exec. VP (Age 56)
  • Mr. John G. Chou, Exec. VP and Chief Legal & Bus. Officer (Age 63)
  • Dr. Robert P. Mauch PharmD, Ph.D., Exec. VP & Group Pres (Age 52)
  • Mr. Dale B. Danilewitz, Exec. VP & Chief Information Officer (Age 57)

What is AmerisourceBergen's stock symbol?

AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."

Who are AmerisourceBergen's major shareholders?

AmerisourceBergen's stock is owned by many different retail and institutional investors. Top institutional investors include Birch Capital Management LLC (0.01%). Company insiders that own AmerisourceBergen stock include Dale Danilewitz, Dermot Mark Durcan, Gina Clark, Henry Wadsworth Mcgee III, James F Cleary Jr, Jane E Md Henney, John G Chou, Kathleen W Hyle, Kathy H Gaddes, Lazarus Krikorian, Richard W Gochnauer, Robert P Mauch, Steven H Collis and Tim G Guttman. View institutional ownership trends for AmerisourceBergen.

Which major investors are selling AmerisourceBergen stock?

ABC stock was sold by a variety of institutional investors in the last quarter, including Birch Capital Management LLC. Company insiders that have sold AmerisourceBergen company stock in the last year include Gina Clark, Henry Wadsworth Mcgee III, Jane E Md Henney, John G Chou, Kathleen W Hyle, Kathy H Gaddes, Lazarus Krikorian, Robert P Mauch, and Steven H Collis. View insider buying and selling activity for AmerisourceBergen.

How do I buy shares of AmerisourceBergen?

Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AmerisourceBergen's stock price today?

One share of ABC stock can currently be purchased for approximately $100.77.

How big of a company is AmerisourceBergen?

AmerisourceBergen has a market capitalization of $20.50 billion and generates $179.59 billion in revenue each year. The company earns $855.36 million in net income (profit) each year or $7.09 on an earnings per share basis. AmerisourceBergen employs 22,000 workers across the globe.

What is AmerisourceBergen's official website?

The official website for AmerisourceBergen is www.amerisourcebergen.com.

How can I contact AmerisourceBergen?

AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at 610-727-7000 or via email at [email protected]

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.